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Abstract
Background—Although mental disorders are significant predictors of educational attainment 
throughout the entire educational career, most research on mental disorders among students has 
focused on the primary and secondary school years.
Methods—The World Health Organization World Mental Health Surveys were used to examine 
the associations of mental disorders with college entry and attrition by comparing college students 
(n = 1,572) and nonstudents in the same age range (18–22; n = 4,178), including nonstudents who 
recently left college without graduating (n = 702) based on surveys in 21 countries (4 low/lower-
middle income, 5 upper middle-income, 1 lower-middle or upper-middle at the times of two 
different surveys, and 11 high income). Lifetime and 12-month prevalence and age-of-onset of 
DSM-IV anxiety, mood, behavioural and substance disorders were assessed with the Composite 
International Diagnostic Interview.
Results—One-fifth (20.3%) of college students had 12-month DSM-IV/CIDI disorders. 83.1% of 
these cases had pre-matriculation onsets. Disorders with pre-matriculation onsets were more 
important than those with post-matriculation onsets in predicting subsequent college attrition, with 
substance disorders and, among women, major depression the most important such disorders. Only 
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16.4% of students with 12-month disorders received any 12-month healthcare treatment for their 
mental disorders.
Conclusions—Mental disorders are common among college students, have onsets that mostly 
occur prior to college entry, in the case of pre-matriculation disorders are associated with college 
attrition, and are typically untreated. Detection and effective treatment of these disorders early in 
the college career might reduce attrition and improve educational and psychosocial functioning.
Keywords
Mental Illness; College; Education; College Dropout; College attrition; Epidemiology
INTRODUCTION
Although prevalence (Costello et al., 2005; Merikangas et al., 2009) and treatment (Fazel et 
al., 2014a; Fazel et al., 2014b) of mental disorders among elementary and secondary school 
students has been the subject of considerable attention, less is known about mental disorder 
prevalence or treatment among college students other than in the United States (Eisenberg et 
al., 2007; Blanco et al., 2008; Cho et al., 2015; Kendler et al., 2015; Mojtabai et al., 2015). 
We know somewhat more about the associations of early-onset mental disorders with 
significant reductions in subsequent educational attainment (Kessler et al., 1995; Fergusson 
& Horwood, 1998; Johnson et al., 1999; Miech et al., 1999; Woodward & Fergusson, 2001; 
Fergusson & Woodward, 2002; Fletcher, 2008; Lee et al., 2009; Mojtabai et al., 2015), but 
this work is limited by either being based on small restricted samples or by being subject to 
long-term recall bias. Given the importance of an educated workforce for the human capital 
potential of a country, it would be valuable to know more about five questions: First, what is 
the prevalence of mental disorders among college students? Second, what proportion of 
those disorders had onsets prior to college entry? Third, to what extent are disorders with 
pre-matriculation onsets associated with college entry? Fourth, what is the relative 
importance of disorders with pre-matriculation and post-matriculation onsets in predicting 
college attrition? Fifth, what proportion of college students with mental disorders receives 
treatment? We address these five questions using data from community epidemiological 
surveys carried out in 21 different countries in the WHO World Mental Health (WMH) 
Survey Initiative.
METHOD
Samples
The WMH surveys are a cross-national series of community epidemiological surveys using 
consistent sampling designs, field procedures, and instruments to facilitate pooled cross-
national comparative analyses (Kessler & Üstun, 2011). The focus is on prevalence and 
correlates of common mental disorders. The data reported here come from the 23 WMH 
surveys carried out in 21 countries that assessed college student status and had a sufficiently 
large sample to: (i) estimate prevalence among college students ages 18–22; and (ii) estimate 
and compare prevalence in disaggregated subsamples of nonstudents in the same age range 
as students, distinguishing college attriters from respondents who never entered college. The 
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18–22 age range was chosen because the vast majority of college students were in that age 
range across countries. We excluded college graduates because it was rare to find them in the 
18–22 age range.
The surveys were carried out in 21 countries: 5 classified by the World Bank (2012) as low 
or lower-middle income countries (national surveys in Colombia, Iraq, and Peru, a regional 
survey in Nigeria, and regional surveys in Beijing-Shanghai and Shenzhen in the People’s 
Republic of China [PRC]), 6 classified as upper-middle-income countries (national surveys 
in Bulgaria, Lebanon, Mexico, and Romania and regional surveys in São Paulo Brazil and 
Medellin Colombia), and 11 classified as high income countries (national surveys in 
Australia, Belgium, France, Italy, Netherlands, New Zealand, Northern Ireland, Poland, 
Portugal, Spain, and the United States). The national survey in Colombia was classified as 
lower-middle income but the regional survey in Medellin Colombia upper-middle income 
because the World Bank classification of Colombia’s income level changed between the 
times of the two surveys.
Each WMH survey was based on a probability sample of household residents using a multi-
stage clustered area probability sample design. Response rates ranged between 50.4% 
(Poland) and 97.2% (Colombia) with a weighted mean of 71.4% across surveys. A detailed 
description of sampling procedures is presented elsewhere (Heeringa et al., 2008). We focus 
here on all respondents in the age range 18–22 who were either college students (n=1,572), 
college attriters (n=702), secondary school graduates who never went to college (n=1,571), 
or people who never completed secondary school (n=1,905). We exclude the small number 
of 18–22 year olds in the surveys who were college graduates (n=183) because this was an 
uncommon outcome. In order to increase precision of prevalence comparisons, the joint age-
sex distributions of students and nonstudents within each country were standardized to equal 
the pooled student distribution across all countries combined. All results reported here 
combine men and women. However, all analyses were also carried out in separate samples 
of men and women (detailed results are available on request) and important differences in 
results are noted throughout the text.
Field procedures
Interviews were administered face-to-face in respondent homes (or, in the case of students 
living in campus group housing, in their student residences) after obtaining informed 
consent using procedures approved by local Institutional Review Boards. All procedures 
used complied with the ethical standards of the relevant national and institutional 
committees on human experimentation and with the Helsinki Declaration of 1975 as revised 
in 2008. The interview schedule was developed in English and translated into other 
languages using a standardized WHO protocol (Harkness et al., 2008). Interviews were 
administered in two parts. Part I, administered to all respondents, assessed core DSM-IV 
mental disorders. Part II assessed additional disorders and correlates. Part II was 
administered to 100% of Part I respondents who met lifetime criteria for any Part I disorder 
and a probability subsample of other Part I respondents. Part II respondents were weighted 
to adjust for differential probabilities of selection into Part II, making estimates of 
prevalence in the weighted Part II sample identical to those in the Part I sample. The current 
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analysis is based on the Part II sample. More details about WMH sample design and 
weighting are presented elsewhere (Heeringa et al., 2008).
Measures
Student status—All respondents were asked if they were currently students or had 
finished their education and how many years of education they had completed. College 
students were defined as those in the age range 18–22 who had completed secondary school 
and were currently students (either part-time or full-time). College students were compared 
to college attriters (i.e., respondents in the same age range who completed some college but 
did not graduate and were no longer students) and other nonstudents in the same age range 
with education less than or equal to a secondary school education.
Mental disorders—Mental disorders were assessed with Version 3.0 of the Composite 
International Diagnostic Interview (CIDI, Kessler & Ustun, 2004), a fully-structured 
diagnostic interview administered by trained lay interviewers. DSM-IV criteria are used 
here. The CIDI assessed two lifetime mood disorders (major depressive disorder and 
broadly-defined bipolar disorder [BPD; including BPD-I, BPD-II, and subthreshold BPD, 
which was defined using criteria described elsewhere (Kessler et al., 2006), five lifetime 
anxiety disorders (separation anxiety disorder, panic disorder with or without agoraphobia, 
generalized anxiety disorder [GAD], phobia [either agoraphobia without a history of panic 
disorder, social phobia, or specific phobia], posttraumatic stress disorder [PTSD]), four 
disruptive behaviour disorders (attention-deficit/hyperactivity disorder [ADHD], 
oppositional-defiant disorder, conduct disorder, intermittent explosive disorder), and four 
substance disorders (alcohol abuse with or without dependence; alcohol dependence with 
abuse, drug abuse with or without dependence, drug dependence with abuse). Age-of-onset 
of each disorder was assessed using special probing techniques shown experimentally to 
improve recall accuracy (Knäuper et al., 1999). Age-of-onset reports were used to determine 
whether each respondent had a history of each disorder prior to the typical age of beginning 
college (i.e., ages 0–17). DSM-IV organic exclusion rules and diagnostic hierarchy rules 
were used other than for substance abuse, which was defined with or without dependence. 
As detailed elsewhere (Haro et al., 2006), generally good concordance was found between 
these CIDI diagnoses and blinded clinical diagnoses based on clinical reappraisal interviews 
with the SCID (First et al., 1994).
Treatment of 12-month disorders—Respondents who met criteria for any 12-month 
DSM-IV/CIDI disorder were presented with a list of mental health care providers (e.g., 
psychiatrist, psychologist, psychotherapist), general medical providers (e.g., general 
practitioner, cardiologist or other medical specialist, nurse), human services professionals 
(e.g., social workers, spiritual advisor), alternative therapists-(e.g., herbalist, spiritualist), and 
self-help groups and asked if they ever sought help from each of these types of individuals or 
settings “for problems with your emotions, nerves, or your use of alcohol or drugs,” and, if 
so, how recently they did so. Respondents who reported seeking treatment at any time in the 
past 12 month were then asked how many visits they made in the past over that time period 
to each type of individual or setting. Consistent with earlier WMH analyses (Wang et al., 
2007), we defined minimally adequate treatment as either (i) making at least 4 visits in the 
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past 12 months to any type of treatment provider, (ii) making at least 2 visits and using any 
type of medication for their emotional problems, or (iii) still being in treatment at the time of 
interview.
Analysis methods
All analyses used weighted data. Cross-tabulations were used to estimate 12-month 
prevalence of each DSM-IV/CIDI disorder as of the time of interview and to decompose 
prevalence estimates into those with pre-matriculation onsets (i.e., ages 0–17) and post-
matriculation onsets (ages 18+), noting that the definition of pre-matriculation disorders was 
conservative in that virtually of those classified pre-matriculation did, in fact, start before 
college entry while some unknown number of disorders with onsets after age 17 started 
before the respondent’s college entry. These estimates were made separately for each 
disorder pooled across countries among college students, college attriters, and respondents 
who had never entered college. A second set of cross-tabulations was then estimated for 
lifetime prevalence of each disorder in the total sample separately among respondents in 
each of the same subsamples. Logistic regression analysis was used to estimate the odds-
ratio of 12-month and lifetime prevalence of each disorder within each of three pairs of 
subgroups: (i) students vs. respondents who never entered college, (ii) attriters vs. 
respondents who never entered college, and (iii) students vs. attriters. Logistic regression 
coefficients and standard errors were exponentiated to produce odds-ratios (ORs) with 95% 
confidence intervals (95% CIs). Logistic models included dummy control variables for 
surveys. We also evaluated significance of differences in ORs across countries at different 
income levels. Statistical significance was consistently evaluated using .05-level two-tailed 
tests. The design-based Taylor series method (Wolter, 1985) implemented in the SAS 
software system (SAS Institute Inc., 2010) was used to adjust significance tests for the 
weighting and clustering of observations. Overall fit of the logistic models was assessed by 
calculating area under the receiver operating characteristic curve (AUC).
RESULTS
Distribution of students
An average (mean [standard error]) of 30.9% (0.9) of respondents ages 18–22 across surveys 
were students, with a range between 4.1% (Shenzhen PRC) and 59.0% (Beijing-Shanghai 
PRC and Medellin Colombia) Aggregate rates were similar for males (32.0%) and females 
(29.7%). (Detailed results are available on request.)
What is the 12-month prevalence of DSM-IV/CIDI disorders among college students?
Twelve-month prevalence of any DSM-IV/CIDI disorder was 20.3% among college students 
compared to 25.0% among attriters and 21.4% among other nonstudents. (Table 1) Students 
also had a lower mean number of overall disorders (23.9/100 persons) than either attriters 
(39.7/100) or other nonstudents (32.8/100). Anxiety disorders were the most prevalent class 
of disorders across all groups in the full sample (11.7–14.7%) followed by mood disorders 
(6.0–9.9%), substance disorders (4.5–6.7%), and behavioral disorders (2.8–5.3%). The most 
prevalent individual disorders were phobias (9.0–11.1%) and MDD (4.5–7.7%). Logistic 
models controlling age-sex and survey found that students had significantly higher 
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prevalence than attriters of panic disorder and lower prevalence of behavioral disorders, 
while students had significantly lower prevalence than other nonstudents of quite a few 
disorders (GAD, PTSD, any mood disorder, ADHD, oppositional-defiant disorder, drug 
dependence) as well as of number of disorders.
What proportion of 12-month DSM-IV/CIDI disorders had onsets prior to college entry?
The vast majority (83.1%) of students with 12-month disorders reported pre-matriculation 
onsets. (Table 2) The only disorder-specific exceptions were that post-matriculation onsets 
were more common than pre-matriculation onsets among students for 12-month panic 
disorder (51.8%) and alcohol abuse-dependence (70.0−67.6%) and that post-matriculation 
onsets characterized sizable minorities of students with 12-month GAD (38.4%), PTSD 
(41.3%), mood disorders (41.6%), and drug abuse (46.2%). Relative proportions of pre-
versus post-matriculation onsets were generally comparable among attriters and other 
nonstudents as among students (χ21 = 0.0–3.4, p = .92−.06). The two exceptions to this 
general pattern were that a significantly higher proportion of students (70.0%) than attriters 
(42.5%; χ21 = 8.6, p = .003) with 12-month alcohol abuse had post-matriculation onsets and 
a significantly higher proportion of students (16.9%) than nonstudents (12.3%; χ21 = 5.4, p 
= .020) with any 12-month disorders had at least one such disorder with a post-matriculation 
onset.
Do pre-matriculation onset DSM-IV/CIDI disorders predict college entry
Somewhat smaller proportions of respondents who entered college (25.3%) than those who 
did not (27.2%; 28.2% of those who graduated from secondary school) met criteria for at 
least one lifetime pre-matriculation DSM-IV/CIDI disorder. (Table 3) Mean number of 
disorders was also lower for students (36.2/100) than nonstudents (48.9−46.4/100). Anxiety 
disorders were consistently much more common across these samples (15.7–19.0%) than 
either mood (7.9–8.3%), behavioral (6.8–7.8%), or substance (5.0–6.9%) disorders. Phobia 
was by far the most prevalent individual disorder (11.6–13.9%) followed by major 
depressive disorder (5.8–6.2%). Logistic regression analysis controlling age-sex and survey 
found that history of one or more pre-matriculation disorders was associated with 
significantly reduced odds of subsequent matriculation among respondents who graduated 
from secondary school (OR 0.8; 95% CI 0.7–1.0), although further analysis (detailed results 
available on request) showed that this was true only in high income countries (OR 0.7; 95% 
CI 0.6–0.9). A similar pattern was found for number of disorders. Disaggregated analysis 
showed that a number of individual anxiety (separation anxiety disorder, panic disorder, 
PTSD), behavioral (conduct disorder, oppositional-defiant disorder), and substance (alcohol 
and drug abuse) disorders were implicated in these aggregate associations, with mood 
disorders the only class of disorders not significant in any of the comparisons. Replication of 
these analyses separately among males and females (detailed results available on request) 
revealed that the significant inverse associations between pre-matriculation disorders and 
subsequent matriculation were for the most part stronger among females than males.
Do pre- and post-matriculation onset DSM-IV/CIDI disorders predict college attrition?
A significantly lower proportion of students than attriters had one or more pre-matriculation 
onset mental disorders (22.9% versus 30.3%; t=2.7, p=.007). This pattern is consistent with 
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pre-matriculation disorders predicting subsequent attrition among college students, although 
this difference became nonsignificant in the logistic regression analysis controlling age-sex 
and survey (OR 0.9; 95% CI 0.6–1.1). (Table 4) However, a comparable model that looked 
at number of pre-matriculation disorders (0.1,2.3,4+) found a significantly lower odds of 
being a student than attriter (OR 0.8; 95% CI 0–6–1.0). The individual disorders 
significantly implicated in this association were all substance disorders. The association was 
significant only in high income countries. Replication of these analyses separately among 
males and females (detailed results available on request) showed that pre-matriculation 
alcohol and drug abuse predicted attrition among males (with ORs of 0.2–0.4), while MDD, 
alcohol abuse, and drug dependence were significant among females (with ORs of 0.2–0.6).
A significantly lower proportion of students than attriters also had one or more post-
matriculation onset disorders (6.7% versus 10.9%; t=2.5, p=.006), but again this difference 
became nonsignificant in the logistic regression analysis (OR 1.2; 95% CI 0.8–1.8). A 
parallel model for number of disorders was also insignificant. Logistic regression found only 
one individual disorder, panic disorder, with significantly different odds of post-
matriculation onset among attriters compared to students, but in this case the odds were 
significantly higher, not lower, among students than attriters (OR 5.0; 95% CI 1.1–22.1). 
Replication separately among males and females (detailed results available on request) 
showed that the pattern differed by sex, with the significantly elevated odds of post-
matriculation panic disorder among students compared to attriters confined to males and the 
only significant OR among females involving post-matriculation onset GAD being lower 
among students than attriters (OR 0.2; 95% CI 0.1–0.5).
What proportion of students with 12-month DSM-IV/CIDI disorders receive treatment?
Roughly one-sixth (16.4%) of students with 12-month DSM-IV/CIDI disorders received 
minimally adequate treatment for these disorders in the 12 months before interview. (Table 
5) This treatment rate was not significantly different from that of attriters (16.6%; χ21 = 0.8, 
p = .37) or other nonstudents (10.6%; χ21 = 2.8, p = .09). However, the treatment rate of 
students decreased monotonically with country income level, from 23.1% in high income 
countries, to 11.4% in upper-middle and 6.7% in lower-middle/low income countries (χ22 = 
7.4, p = .025).
DISCUSSION
We presented here the first large-scale cross-national investigation of 12-month and lifetime 
prevalence of mental disorders among college students, the associations of pre- and post-
matriculation mental disorders with college matriculation and attrition, and 12-month 
treatment of mental disorders among college students. The results showed that a substantial 
proportion of college students have 12-month DSM-IV/CIDI disorders, that the vast majority 
of cases had pre-matriculation onsets, that pre-matriculation disorders are associated with 
both reduced odds of college matriculation and elevated odds of attrition, and that only a 
small minority of college students receive even minimally adequate treatment for their 
mental disorders.
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In considering intervention possibilities, an important question unanswered by our results is 
whether the pre-matriculation disorders we found to be associated with attrition are stable. 
This question arises because we made a great many comparisons in the analyses, leading to 
the possibility that some of the associations judged to be significant were false positives. 
Replication is needed to evaluate this issue. This replication would ideally be carried out in a 
prospective sample that assessed student at the time of college entry and follows them 
through their college careers to evaluate the importance of -matriculation predictors of 
college outcomes.
Assuming that this replication supports our finding that pre-matriculation mental disorders 
are associated with attrition, a second important unanswered question is whether these 
disorders are causal risk factors or only risk markers of attrition (Kraemer et al., 1997). Our 
findings that pre-matriculation substance disorders (males and females) and MDD (females) 
predicted subsequent attrition were also found in previous epidemiological studies (Kessler 
et al., 1995; Eisenberg et al., 2009; Hunt et al., 2010; Mojtabai et al., 2015), but none of 
these studies provided any evidence that these disorders are causes rather than non-causal 
correlates. It is plausible to think that the associations are non-causal because risk factors for 
adolescent substance (Kilpatrick et al., 2000) and mood (Lewinsohn et al., 1998; Costello et 
al., 2002) disorders have many similarities with risk factors for college attrition (Ishitani & 
DesJardins, 2002; Stratton et al., 2006; Hartley, 2010), such as high stress, interpersonal 
discord, and diminished social support, none of which we controlled in our analyses. To the 
extent that these (or other) joint predictors account for the associations of pre-matriculation 
mental disorders with college attrition, interventions to detect and treat these pre-existing 
disorders among entering freshmen would not reduce subsequent attrition. On the other 
hand, to the extent that the pre-matriculation disorders associated with college attrition 
represent common causal pathways for many of the more traditional predictors of attrition 
documented by educational researchers, interventions focused on college entrants with these 
pre-existing disorders might be of great value in reducing attrition.
There is no definitive way to adjudicate between these competing possibilities with the data 
presented here. A definitive evaluation would require experimental intervention where 
students with pre-matriculation disorders were detected and randomized either into best-
practices treatments or usual care. Such an intervention would be most feasible in high 
income countries, where access to outpatient mental health treatment in high, even though 
there is wide variation in the number of outpatient mental health workers per 100,000 people 
in the populations of these countries (e.g., 23 in Portugal; 40–46 in the Netherlands, Poland 
and Spain; 125 in the U.S.; 158 in France) (World Health Organization, 2015). Given the 
much lower availability of outpatient mental health treatment providers in upper-middle and 
lower-middle/low income (e.g., 9.5/100,000 in Mexico and 0.9/100,000 in Nigeria), it seems 
unrealistic to think that resources would be available to provide outpatient treatment for 
college students in such countries.
In carrying out such an intervention, a question would arise whether the intervention should 
be limited to active disorders or also include relapse prevention for students with lifetime 
disorders that were not active at the time of matriculation. The results presented here are 
moot on this point because the WMH surveys did not collect data on whether disorders with 
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pre-matriculation onsets were active or remitted at the time of college entry. However, it is 
noteworthy that 12-month prevalence of the pre-matriculation lifetime disorders associated 
with subsequent attrition was generally not more common among attriters than students. If 
pre-matriculation lifetime disorders were causal risk factors rather than risk markers for 
subsequent attrition, we would expect that 12-month presence of these same disorders would 
predict subsequent attrition, in which case our failure to find higher 12-month prevalence 
among attriters than students might be taken as evidence that these pre-matriculation 
disorders were risk markers rather than causal risk factors. It is important to recognize, 
though, that questions about disorder recency were not sufficiently specific in the WMH 
surveys to allow us to determine prevalence in the 12-months prior to attrition. As a result, 
our failure to find higher 12-month prevalence among attriters than students could be due to 
the consequences of attrition (e.g., being dismissed from college leading to a reduction in the 
heavy substance use that led to the dismissal). A similar kind of reciprocal influence might 
account for the fact that disorders with post-matriculation onsets were not more common 
among attriters than students.
Several limitations of our study are noteworthy. Some of these involve sampling. Perhaps the 
most obvious one is that the number of college students in the WMH surveys was too small 
to support separate analyses in each country. We carried out some cross-national analyses 
comparing results in high, upper-middle, and lower-middle/low income countries, but this 
level of disaggregation was less complete than we would have been preferred. The small 
sample sizes also resulted in wide confidence intervals of estimates, with many of the odds-
ratios considered significant having confidence intervals where one bound was very close to 
1.0 and in a number of cases rounded to 1.0 with a single decimal of precision. Another 
sampling-related limitation is that not all WMH surveys included group housing in their 
sample frames. This means that these surveys under-represented students living in campus 
dormitories or fraternity-sorority houses. Most WMH surveys also failed to distinguish 
between students living in off-campus housing with their families versus with roommates. 
These sample limitation have the potential to be important in that some mental disorders 
(e.g., separation anxiety disorder, substance disorders) are likely to be higher among 
students living away from home and possibly more so in group housing than elsewhere.
Another set of limitation involves the assessment of mental disorders. Lifetime mental 
disorders and ages-of-onset were assessed retrospectively. Although the WMH assessment 
used procedures shown experimentally to improve accuracy of recall (Scott et al., 2014), 
there are likely to be downward biases in reports of lifetime prevalence and possibly also in 
dating age-of-onset of disorders due to recall errors. It is unclear whether these biases would 
be different for students, attriters, and respondents who never entered college. In addition, 
diagnoses were based on fully-structured lay-administered interviews rather than semi-
structured clinical interviews, although the WMH clinical appraisal data are reassuring 
(Haro et al., 2006). In addition, we assessed only prevalence, not severity, of disorders. This 
omission could be important given that other research has shown that educational attainment 
is associated not only with prevalence but also severity of mental disorders (Ten Have et al., 
2013).
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A third set of limitations involves the imprecision in our information on timing of disorder 
onset, matriculation, and attrition. This imprecision made it impossible for us to draw firm 
distinctions between mental disorders that occurred before versus after matriculation or, in 
the case of disorders with clear post-matriculation onsets, those that occurred before versus 
subsequent to attrition. Importantly, we dealt with this limitation by erring on the side of 
being conservative by considering only disorders with onsets prior to age 18 as being pre-
matriculation disorders. As a result, correction of this problem would only lead to an 
increase in the strength of our finding that the vast majority of the disorders of college 
students are pre-matriculation disorders.
Despite these limitations, our results are clear in showing that mental disorders are common 
among college students around the world, that the vast majority of these disorders have pre-
matriculation onsets (which, if anything, were under-estimated by our lack of precision in 
the dating of matriculation), and that pre-matriculation mental disorders are associated both 
with failure to enter college and with attrition. We also found that only a small minority of 
college students with mental disorders receive even minimally adequate treatment and that 
the treatment rate is even lower in low-income countries. These results could have important 
human capital implications that would make it cost-effective from a societal perspective to 
invest in screening and increased treatment of college student mental disorders.
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Appendix
Appendix Table 1
WMH sample characteristics by World Bank income categories1
Sample sizes
Country by income 
category Survey2 Sample characteristics3 Field dates Age range Response rate4 Part 1 Part 2
Part 2 age 
18–22 and 
not 
graduated 
from 
college
I. Low and lower middle income countries
 China - Beijing/Shanghai B-WMH/S-WMH Beijing and Shanghai 
metropolitan areas.
2002–3 18–70 74.7 5,201 1,628 133
 China - Shenzhen5 Shenzhen Shenzhen metropolitan 
area. Included temporary 
residents as well as 
household residents.
2006–7 18–88 80.0 7,132 2,475 426
 Colombia NSMH All urban areas of the 
country (approximately 
73% of the total national 
population)
2003 18–65 87.7 4,426 2,381 337
 Iraq IMHS Nationally representative. 2006–7 18–96 95.2 4,332 4,332 561
 Nigeria NSMHW 21 of the 36 states in the 
country, representing 57% 
of the national population. 
The surveys were 
conducted in Yoruba, Igbo, 
Hausa and Efik languages.
2002–3 18–100 79.3 6,752 2,143 217
 Peru EMSMP Nationally representative. 2004–5 18–65 90.2 3,930 1,801 251
 Total 82.9 (31,773) (14,760) (1,925)
II. Upper-middle income countries
 Brazil - São Paulo São Paulo Megacity São Paulo metropolitan 
area.
2005–7 18–93 81.3 5,037 2,942 262
 Bulgaria NSHS Nationally representative. 2003–7 18–98 72.0 5,318 2,233 74
 Colombia - Medellin6 MMHHS Medellin metropolitan area 2011–12 19–65 97.2 3,261 1,673 147
 Lebanon LEBANON Nationally representative. 2002–3 18–94 70.0 2,857 1,031 79
 Mexico M-NCS All urban areas of the 
country (approximately 
75% of the total national 
population).
2001–2 18–65 76.6 5,782 2,362 372
 Romania RMHS Nationally representative. 2005–6 18–96 70.9 2,357 2,357 102
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Sample sizes
Country by income 
category Survey2 Sample characteristics3 Field dates Age range Response rate4 Part 1 Part 2
Part 2 age 
18–22 and 
not 
graduated 
from 
college
 Total 77.2 (24,612) (12,598) (1,036)
III. High income countries
 Australia5 NSMHWB Nationally representative. 2007 18–85 60.0 8,463 8,463 649
 Belgium ESEMeD Nationally representative. 
The sample was selected 
from a national register of 
Belgium residents
2001–2 18–95 50.6 2,419 1,043 41
 France ESEMeD Nationally representative. 
The sample was selected 
from a national list of 
households with listed 
telephone numbers.
2001–2 18–97 45.9 2,894 1,436 76
 Italy ESEMeD Nationally representative. 
The sample was selected 
from municipality resident 
registries.
2001–2 18–100 71.3 4,712 1,779 108
 Netherlands ESEMeD Nationally representative. 
The sample was selected 
from municipal postal 
registries.
2002–3 18–95 56.4 2,372 1,094 31
 New Zealand5 NZMHS Nationally representative. 2003–4 18–98 73.3 12,790 7,312 545
 Northern Ireland NISHS Nationally representative. 2004–7 18–97 68.4 4,340 1,986 144
 Poland EZOP Nationally representative. 2010–11 18–65 50.4 10,081 4,000 432
 Portugal NMHS Nationally representative. 2008–9 18–81 57.3 3,849 2,060 113
 Spain ESEMeD Nationally representative. 2001–2 18–98 78.6 5,473 2,121 113
 United States NCS-R Nationally representative. 2002–3 18–99 70.9 9,282 5,692 537
 Total 80.6 (20,940) (11,101) (2,789)
IV. Total 71.4 (51,002) (25,819) (5,750)
1
The World Bank (2012) Data. Accessed May 12, 2012 at: http://data.worldbank.org/country. Some of the WMH countries 
have moved into new income categories since the surveys were conducted. The income groupings above reflect the status of 
each country at the time of data collection. The current income category of each country is available at the preceding URL.
2NSMH (The Colombian National Study of Mental Health); IMHS (Iraq Mental Health Survey); NSMHW (The Nigerian 
Survey of Mental Health and Wellbeing); B-WMH (The Beijing World Mental Health Survey); S-WMH (The Shanghai 
World Mental Health Survey); EMSMP (La Encuesta Mundial de Salud Mental en el Peru); (Bulgaria National Survey of 
Health and Stress); MMHHS (Medellín Mental Health Household Study); LEBANON (Lebanese Evaluation of the Burden 
of Ailments and Needs of the Nation); M-NCS (The Mexico National Comorbidity Survey); RMHS (Romania Mental 
Health Survey); NSMHWB (National Survey of Mental Health and Wellbeing); ESEMeD (The European Study Of The 
Epidemiology Of Mental Disorders); NZMHS (New Zealand Mental Health Survey); NISHS (Northern Ireland Study of 
Health and Stress); EZOP (Epidemiology of Mental Disorders and Access to Care Survey); NMHS (Portugal National 
Mental Health Survey); PEGASUS-Murcia (Psychiatric Enquiry to General Population in Southeast Spain-Murcia); NCS-R 
(The US National Comorbidity Survey Replication).
3
Most WMH surveys are based on stratified multistage clustered area probability household samples in which samples of 
areas equivalent to counties or municipalities in the US were selected in the first stage followed by one or more subsequent 
stages of geographic sampling (e.g., towns within counties, blocks within towns, households within blocks) to arrive at a 
sample of households, in each of which a listing of household members was created and one or two people were selected 
from this listing to be interviewed. No substitution was allowed when the originally sampled household resident could not 
be interviewed. These household samples were selected from Census area data in all countries other than France (where 
telephone directories were used to select households) and the Netherlands (where postal registries were used to select 
Auerbach et al. Page 14
Psychol Med. Author manuscript; available in PMC 2017 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
households). Several WMH surveys (Belgium, Italy) used municipal resident registries to select respondents without listing 
households. 16 of the 23 surveys are based on nationally representative household samples.
4
The response rate is calculated as the ratio of the number of households in which an interview was completed to the 
number of households originally sampled, excluding from the denominator households known not to be eligible either 
because of being vacant at the time of initial contact or because the residents were unable to speak the designated languages 
of the survey. The weighted average response rate is 71.4%.
5
For the purposes of cross-national comparisons we limit the sample to those 18+.
6Colombia moved from the “lower and lower-middle income” to the “upper-middle income” category between 2003 (when 
the Colombian National Study of Mental Health was conducted) and 2010 (when the Medellin Mental Health Household 
Study was conducted), hence Colombia’s appearance in both income categories. For more information, please see footnote 
1.
Appendix Table 2
Distribution of Part II WMH survey respondents ages 18–22 in participating surveys by 
country income level and respondent education and student status1
College entrants
Other respondents who were secondary 
school…
Total
Students Attriters Graduates Non-graduates
% (se) % (se) % (se) % (se) (n)
I. Low and lower-middle
 China - Beijing/Shanghai 59.0 (5.3) 13.9 (2.7) 20.9 (4.1) 6.2 (1.7) (133)
 China - Shenzhen 4.1 (0.4) 10.6 (1.4) 30.2 (2.5) 55.1 (2.6) (426)
 Colombia 32.6 (5.3) 13.3 (2.5) 30.3 (3.5) 23.9 (2.9) (337)
 Iraq 18.8 (2.6) 3.0 (0.8) 8.7 (2.1) 69.4 (2.4) (561)
 Nigeria 44.0 (4.3) 2.3 (0.6) 23.1 (3.2) 30.6 (3.7) (217)
 Peru 40.7 (3.7) 8.2 (1.7) 39.1 (3.0) 12.0 (2.3) (251)
II. Upper-middle
 Brazil - São Paulo 7.1 (2.4) 13.5 (2.6) 55.9 (3.8) 23.5 (3.1) (262)
 Bulgaria 34.9 (4.9) 0.4 (0.4) 41.4 (4.2) 23.4 (4.1) (74)
 Colombia - Medellin 59.0 (7.1) 13.6 (3.3) 13.0 (3.7) 14.4 (4.8) (147)
 Lebanon 42.6 (5.0) 6.7 (2.6) 15.0 (4.7) 35.7 (4.5) (79)
 Mexico 23.1 (2.6) 4.7 (1.2) 12.0 (1.9) 60.2 (3.3) (372)
 Romania 27.3 (7.2) 0.5 (0.0) 26.9 (5.5) 45.3 (7.4) (102)
III. High
 Australia 44.0 (2.3) 16.5 (1.7) 17.1 (1.8) 22.4 (1.9) (649)
 Belgium 39.9 (8.9) 29.7 (7.2) 26.6 (6.3) 3.7 (2.1) (41)
 France 15.3 (4.5) 26.7 (6.4) 58.1 (6.4) 0.0 (0.0) (76)
 Italy 19.3 (3.2) 14.8 (3.9) 40.3 (3.7) 25.6 (4.2) (108)
 Netherlands 56.5 (7.7) 34.7 (7.2) 4.6 (3.2) 4.2 (1.3) (31)
 New Zealand 30.0 (3.8) 5.3 (1.1) 25.0 (2.4) 39.7 (3.1) (545)
 Northern Ireland 35.1 (3.8) 37.0 (5.1) 27.9 (4.6) 0.0 (0.0) (144)
 Poland 42.5 (3.4) 0.2 (0.2) 41.6 (2.7) 15.6 (2.1) (432)
 Portugal 46.8 (3.6) 1.9 (0.4) 19.0 (2.8) 32.4 (4.4) (113)
 Spain 49.8 (4.7) 23.3 (4.7) 6.9 (1.8) 20.0 (3.0) (113)
 United States 23.7 (3.5) 21.5 (2.1) 34.2 (3.6) 20.5 (2.4) (537)
1
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
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Appendix Table 3
Distribution of Part II WMH male survey respondents ages 18–22 in participating surveys 
by education and student status1
College entrants
Other respondents who were secondary 
school…
Total
Students Attriters Graduates Non-graduates
% (se) % (se) % (se) % (se) (n)
I. Low and lower-middle
 China - Beijing/Shanghai 57.4 (7.8) 8.1 (2.4) 22.8 (5.8) 11.8 (2.8) (74)
 China - Shenzhen 6.1 (1.0) 11.2 (3.3) 30.3 (4.6) 52.5 (5.7) (163)
 Colombia 27.6 (6.1) 13.6 (3.6) 32.7 (5.4) 26.1 (3.8) (138)
 Iraq 21.7 (3.9) 3.9 (1.4) 9.0 (2.6) 65.3 (4.3) (277)
 Nigeria 55.1 (5.8) 2.9 (0.6) 14.4 (3.6) 27.5 (4.8) (107)
 Peru 39.7 (4.0) 7.2 (2.0) 41.5 (3.5) 11.5 (4.3) (125)
II. Upper-middle
 Brazil - São Paulo 4.9 (2.2) 13.3 (4.6) 60.3 (5.1) 21.5 (5.1) (110)
 Bulgaria 37.6 (5.9) 0.0 (0.0) 40.3 (5.9) 22.1 (6.3) (32)
 Colombia - Medellin 65.4 (9.8) 9.1 (3.2) 9.2 (3.6) 16.2 (8.3) (65)
 Lebanon 53.0 (6.4) 1.0 (1.0) 13.3 (3.8) 32.8 (6.3) (33)
 Mexico 24.1 (4.0) 4.8 (1.8) 11.8 (2.3) 59.4 (4.4) (155)
 Romania 22.8 (7.7) 1.0 (0.2) 33.9 (9.0) 42.3 (7.8) (44)
III. High
 Australia 47.8 (3.2) 14.2 (2.1) 17.3 (2.4) 20.8 (2.4) (302)
 Belgium 40.9 (14.1) 18.3 (9.0) 36.6 (12.6) 4.2 (3.5) (16)
 France 12.5 (6.7) 32.9 (9.5) 54.6 (9.6) 0.0 (0.0) (34)
 Italy 24.8 (5.0) 20.4 (6.9) 29.1 (3.6) 25.7 (7.2) (44)
 Netherlands 38.6 (12.8) 54.4 (12.6) 7.1 (5.7) 0.0 (0.0) (13)
 New Zealand 25.4 (4.1) 4.0 (1.4) 26.8 (3.2) 43.9 (4.0) (236)
 Northern Ireland 37.1 (7.1) 36.5 (8.7) 26.4 (6.6) 0.0 (0.0) (62)
 Poland 38.1 (4.6) 0.5 (0.5) 42.3 (4.0) 19.0 (3.1) (201)
 Portugal 43.3 (6.5) 3.1 (0.4) 14.4 (4.9) 39.2 (7.0) (48)
 Spain 57.1 (6.4) 17.2 (4.5) 10.3 (2.8) 15.3 (5.8) (51)
 United States 23.5 (4.8) 20.5 (2.3) 30.5 (3.8) 25.6 (3.3) (237)
1
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
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Appendix Table 4
Distribution of Part II WMH female survey respondents ages 18–22 in participating surveys 
by education and student status1
College entrants
Other respondents who were secondary 
school…
Total
Students Attriters graduates non-graduates
% (se) % (se) % (se) % (se) (n)
I. Low and lower-middle
 China - Beijing/Shanghai 60.8 (6.1) 20.3 (4.9) 18.8 (5.8) 0.0 (0.0) (59)
 China - Shenzhen 3.0 (0.9) 10.3 (1.7) 30.2 (3.5) 56.6 (4.1) (263)
 Colombia 36.8 (7.8) 13.0 (3.7) 28.3 (4.9) 22.0 (4.2) (199)
 Iraq 15.6 (3.1) 2.0 (0.6) 8.4 (2.6) 74.0 (3.4) (284)
 Nigeria 33.0 (4.6) 1.7 (0.8) 31.6 (5.2) 33.7 (4.5) (110)
 Peru 41.6 (5.2) 9.1 (2.9) 36.9 (4.8) 12.5 (2.8) (126)
II. Upper-middle
 Brazil - São Paulo 9.5 (4.2) 13.6 (3.3) 51.3 (5.1) 25.6 (3.9) (152)
 Bulgaria 31.7 (8.8) 0.8 (0.9) 42.6 (7.4) 24.9 (6.3) (42)
 Colombia - Medellin 51.7 (8.6) 18.6 (5.8) 17.3 (6.6) 12.3 (4.3) (82)
 Lebanon 28.3 (6.4) 14.6 (5.0) 17.4 (8.6) 39.8 (7.5) (46)
 Mexico 22.0 (4.0) 4.6 (1.7) 12.2 (3.2) 61.2 (5.5) (217)
 Romania 31.3 (10.2) 0.0 (0.0) 20.8 (5.0) 47.9 (10.9) (58)
III. High
 Australia 40.0 (3.0) 18.9 (2.4) 16.9 (2.6) 24.1 (2.7) (347)
 Belgium 38.5 (8.5) 45.2 (7.0) 13.2 (6.7) 3.1 (0.5) (25)
 France 18.5 (4.1) 19.3 (7.1) 62.2 (8.3) 0.0 (0.0) (42)
 Italy 13.8 (4.2) 9.0 (1.6) 51.8 (6.3) 25.4 (4.9) (64)
 Netherlands 80.8 (5.3) 8.1 (2.3) 1.3 (0.7) 9.9 (3.7) (18)
 New Zealand 34.4 (4.9) 6.6 (1.7) 23.3 (3.0) 35.7 (3.8) (309)
 Northern Ireland 33.1 (4.0) 37.5 (5.5) 29.4 (4.3) 0.0 (0.0) (82)
 Poland 46.7 (3.7) 0.0 (0.0) 40.9 (3.4) 12.3 (2.6) (231)
 Portugal 50.1 (3.6) 0.8 (0.7) 23.3 (4.5) 25.8 (5.7) (65)
 Spain 43.3 (5.0) 28.7 (7.6) 3.9 (2.2) 24.1 (4.1) (62)
 United States 24.0 (3.8) 22.5 (4.0) 37.9 (4.9) 15.6 (3.4) (300)
1
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
Appendix Table 5
Pooled 12-month prevalence of DSM-IV/CIDI mental disorders separately among male 
respondents ages 18–22 who were current students, college attriters, and nonstudents in the 
same age range1
Students (ST) Attriters (AT) Other (OT) ST:AT2 ST:OT2
% (se) % (se) % (se) OR (95 % CI) OR (95 % CI) AUC3
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Students (ST) Attriters (AT) Other (OT) ST:AT2 ST:OT2
% (se) % (se) % (se) OR (95 % CI) OR (95 % CI) AUC3
I. Anxiety disorders
 Separation Anxiety Disorder 1.9 (1.4) 0.7 (0.3) 1.0 (0.3) 3.4 (0.6–19.3) 2.0 (0.4–11.0) 0.81
 Panic Disorder 1.5 (0.6) 0.7 (0.5) 1.0 (0.2) 5.2 (0.8–34.1) 1.4 (0.6–3.3) 0.75
 GAD 0.2 (0.1) 0.8 (0.5) 0.8 (0.3) 0.4 (0.1–3.2) 0.3 (0.1–1.1) 0.74
 Any Phobia 5.3 (1.0) 8.1 (2.7) 6.8 (0.7) 0.7 (0.3–1.4) 0.7 (0.5–1.1) 0.69
 PTSD 0.7 (0.4) 0.8 (0.5) 0.6 (0.3) 1.7 (0.3–8.8) 1.1 (0.3–4.8) 0.75
 Any 8.6 (1.7) 10.0 (2.7) 8.6 (0.8) 1.0 (0.5–2.0) 1.0 (0.6–1.6) 0.66
II. Mood disorders
 MDD 3.2 (0.7) 6.0 (1.2) 3.7 (0.5) 0.8 (0.4–1.7) 0.8 (0.5–1.3) 0.62
 Bipolar 1.1 (0.3) 2.2 (0.6) 2.9 (0.5) 0.7 (0.3–1.9) 0.3* (0.2–0.7) 0.79
 Any 4.3 (0.8) 8.3 (1.3) 6.6 (0.7) 0.8 (0.4–1.5) 0.6* (0.4–0.9) 0.68
III. Behavior disorders
 ADHD 0.5 (0.2) 2.0 (1.3) 0.7 (0.2) 0.3 (0.1–1.4) 0.6 (0.2–1.8) 0.83
 Conduct Disorder 0.3 (0.2) 0.8 (0.7) 0.7 (0.2) 0.3 (0.0–3.5) 0.4 (0.1–1.8) 0.84
 ODD 0.4 (0.2) 1.0 (0.7) 0.5 (0.2) 0.3 (0.1–1.7) 0.7 (0.2–2.8) 0.86
 IED 3.1 (0.7) 3.0 (1.0) 2.8 (0.4) 1.0 (0.5–2.0) 1.0 (0.6–1.7) 0.80
 Any 4.1 (0.8) 5.9 (1.7) 4.3 (0.5) 0.7 (0.3–1.3) 0.8 (0.5–1.3) 0.77
IV. Substance disorders
 Alcohol Abuse 3.3 (0.7) 4.7 (1.4) 4.4 (0.5) 0.9 (0.4–2.0) 0.7 (0.4–1.1) 0.71
 Alcohol Dependence 1.4 (0.5) 1.3 (0.5) 2.5 (0.4) 1.2 (0.4–3.5) 0.5 (0.2–1.2) 0.76
 Drug Abuse 0.9 (0.5) 1.2 (0.6) 1.6 (0.3) 0.8 (0.2–3.2) 0.5 (0.2–1.6) 0.81
 Drug Dependence 0.4 (0.3) 1.2 (0.7) 1.4 (0.3) 0.5 (0.1–3.1) 0.3* (0.1–1.0) 0.84
 Any 5.7 (1.0) 7.3 (1.6) 8.6 (0.8) 1.0 (0.5–1.9) 0.6 (0.4–0.9) 0.74
V. Total disorders
 Any 17.9 (2.0) 22.3 (3.2) 19.7 (1.2) 0.9 (0.6–1.5) 0.8 (0.6–1.1) 0.68
  (n) (747) (270) (1,550) – – –
*Significant at the .05 level, two-sided test
1
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
2
Based on a pooled within-survey logistic regression model adjusting for between-survey variation in the association of 
age-sex with student status.
3
The AUCs were generated from logistic models in which dummy variables for being an attriter or other nonstudent were 
included as predictors of the mental disorder in the row heading or, in the case of Part VI, number of disorders estimated in 
an order logistic framework, controlling age-sex and survey.
Appendix Table 6
Pooled 12-month prevalence of DSM-IV/CIDI mental disorders separately among female 
respondents ages 18–22 who were current students, college attriters, and nonstudents in the 
same age range1
Students (ST) Attriters (AT) Other (OT) ST:AT2 ST:OT2
% (se) % (se) % (se) OR (95 % CI) OR (95 % CI) AUC3
I. Anxiety disorders
Auerbach et al. Page 18
Psychol Med. Author manuscript; available in PMC 2017 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Students (ST) Attriters (AT) Other (OT) ST:AT2 ST:OT2
% (se) % (se) % (se) OR (95 % CI) OR (95 % CI) AUC3
 Separation Anxiety Disorder 0.7 (0.2) 2.2 (0.9) 1.4 (0.2) 0.4 (0.2–1.1) 0.4* (0.2–0.9) 0.86
 Panic Disorder 1.0 (0.2) 1.5 (0.4) 1.7 (0.3) 1.4 (0.7–2.9) 0.5* (0.3–0.9) 0.75
 GAD 0.7 (0.2) 0.8 (0.3) 0.8 (0.2) 1.2 (0.4–3.4) 0.7 (0.4–1.5) 0.75
 Any Phobia 12.8 (2.0) 13.8 (1.4) 12.8 (0.9) 1.0 (0.6–1.5) 1.0 (0.7–1.5) 0.66
 PTSD 2.0 (0.5) 4.4 (1.0) 3.3 (0.5) 0.8 (0.4–1.6) 0.5* (0.3–0.9) 0.79
 Any 15.1 (2.0) 19.0 (1.8) 17.1 (1.0) 1.0 (0.7–1.4) 0.8 (0.6–1.2) 0.67
II. Mood disorders
 MDD 5.8 (0.8) 9.2 (1.4) 6.3 (0.6) 0.7 (0.4–1.1) 0.9 (0.6–1.3) 0.67
 Bipolar 2.5 (0.7) 2.4 (0.7) 2.4 (0.3) 1.5 (0.7–3.5) 1.0 (0.5–1.9) 0.72
 Any 7.8 (1.0) 11.5 (1.5) 8.7 (0.7) 0.8 (0.5–1.2) 0.9 (0.6–1.2) 0.68
III. Behavior disorders
 ADHD 0.2 (0.2) 1.1 (0.3) 1.1 (0.2) 0.4 (0.1–2.4) 0.2 (0.0–1.3) 0.83
 Conduct Disorder 0.0 (0.0) 0.0 (0.0) 0.2 (0.1) – – – – –
 ODD 0.0 (0.0) 1.0 (0.7) 0.8 (0.1) 0.0* (0.0–0.6) 0.0* (0.0–0.2) 0.85
 IED 1.5 (0.4) 3.1 (0.9) 2.1 (0.3) 0.5 (0.3–1.1) 0.7 (0.4–1.4) 0.83
 Any 1.6 (0.4) 4.8 (1.1) 3.3 (0.4) 0.4 (0.2–0.8) 0.4* (0.3–0.8) 0.82
IV. Substance disorders
 Alcohol Abuse 1.7 (0.3) 3.7 (1.2) 1.9 (0.4) 0.6 (0.3–1.3) 0.8 (0.4–1.4) 0.80
 Alcohol Dependence 1.3 (0.5) 2.0 (0.9) 0.6 (0.2) 1.3 (0.4–4.7) 1.8 (0.7–4.8) 0.77
 Drug Abuse 0.5 (0.2) 1.4 (0.8) 0.4 (0.1) 0.6 (0.2–2.1) 1.1 (0.5–2.4) 0.83
 Drug Dependence 0.1 (0.1) 1.1 (0.5) 0.4 (0.1) 0.1* (0.0–0.7) 0.2 (0.0–1.2) 0.81
 Any 3.3 (0.6) 6.2 (1.6) 3.0 (0.4) 0.8 (0.4–1.6) 0.9 (0.6–1.5) 0.78
V. Total disorders
 Any 22.8 (2.1) 27.5 (2.4) 23.1 (1.1) 1.0 (0.7–1.4) 0.9 (0.7–1.2) 0.68
 (n) (825) (432) (1,926) – – –
*Significant at the .05 level, two-sided test
1
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
2
Based on a pooled within-survey logistic regression model adjusting for between-survey variation in the association of 
age-sex with student status.
3
The AUCs were generated from logistic models in which dummy variables for being an attriter or other nonstudent were 
included as predictors of the mental disorder in the row heading or, in the case of Part VI, number of disorders estimated in 
an order logistic framework, controlling age-sex and survey.
Appendix Table 7
Pooled percentages of 12-month DSM-IV/CIDI disorders with pre-matriculation onsets1 
separately among male respondents ages 18–22 who were current students, college attriters, 
and nonstudents2 in the same age range3
Students (ST) Attriters (AT) Other4 (OT) ST vs. AT ST vs. OT
% (se) % (se) % (se) χ2 χ2
I. Anxiety disorders
 Separation Anxiety Disorder 79.6 (18.1) 51.9 (23.5) 75.0 (9.7) 0.0 0.2
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Students (ST) Attriters (AT) Other4 (OT) ST vs. AT ST vs. OT
% (se) % (se) % (se) χ2 χ2
 Panic Disorder 28.1 (15.5) 100.0 (0.0) 67.9 (8.5) – 0.4
 GAD 24.5 (19.6) 77.0 (21.7) 78.3 (11.5) 53.2* 742.2*
 Any Phobia 93.4 (4.5) 77.5 (10.9) 98.8 (0.7) 0.3 7.9*
 PTSD 65.2 (23.2) 100.0 (0.0) 75.9 (14.4) – 0.0
 Any 88.0 (3.9) 78.3 (9.0) 93.6 (1.6) 0.0 3.1
II. Mood disorders
 MDD 31.4 (9.9) 51.9 (10.0) 58.3 (6.5) 0.1 3.6
 Bipolar 68.8 (14.9) 72.1 (10.9) 66.9 (7.0) 0.7 0.0
 Any 40.7 (8.6) 57.4 (8.5) 61.6 (5.2) 0.4 2.2
III. Behavior disorders
 ADHD 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) – –
 Conduct Disorder 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) – –
 ODD 100.0 (0.0) 100.0 (0.0) 97.4 (2.7) – –
 IED 94.8 (3.1) 94.3 (3.4) 88.1 (3.5) 0.0 0.6
 Any 96.0 (2.4) 97.0 (1.7) 94.2 (1.9) 0.0 0.0
IV. Substance disorders
 Alcohol Abuse 32.8 (7.8) 66.1 (13.8) 44.1 (6.0) 10.9* 3.3
 Alcohol Dependence 44.1 (18.9) 33.7 (17.5) 51.2 (7.2) 0.2 0.8
 Drug Abuse 72.0 (18.3) 60.2 (21.4) 58.7 (9.4) 0.5 0.1
 Drug Dependence 100.0 (0.0) 76.9 (17.6) 60.7 (9.7) – –
 Any 58.4 (8.1) 65.2 (10.4) 58.2 (4.2) 0.3 0.2
V. Total disorders
 Any 78.3 (3.8) 81.4 (4.9) 84.9 (2.1) 0.9 4.5*
*Significant at the .05 level.
1
Pre-matriculation onset disorders were defined as those with onsets at ages 0–17.
2
Post-matriculation onset disorders were defined as those with onsets at ages 18+.
3
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
4
“All other” respondents were defined as those who never entered college whether or not they graduated from secondary 
school.
Appendix Table 8
Pooled percentages of 12-month DSM-IV/CIDI disorders with pre-matriculation onsets1 
separately among female respondents ages 18–22 who were current students, college 
attriters, and nonstudents2 in the same age range3
Students (ST) Attriters (AT) Other4 (OT) ST vs. AT ST vs. OT
% (se) % (se) % (se) χ2 χ2
I. Anxiety disorders
 Separation Anxiety Disorder 42.0 (13.1) 42.9 (21.7) 54.0 (8.5) 0.3 2.3
 Panic Disorder 80.0 (5.4) 64.6 (16.5) 93.7 (3.7) 0.0 0.5
 GAD 75.4 (8.4) 24.0 (15.4) 75.5 (6.5) 272.1* 1.6
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Students (ST) Attriters (AT) Other4 (OT) ST vs. AT ST vs. OT
% (se) % (se) % (se) χ2 χ2
 Any Phobia 96.6 (0.7) 96.4 (1.6) 97.0 (1.3) 0.2 0.4
 PTSD 56.2 (11.6) 69.6 (10.2) 77.6 (5.6) 0.0 1.3
 Any 93.9 (1.5) 91.1 (2.3) 93.9 (1.4) 0.1 0.0
II. Mood disorders
 MDD 66.7 (6.0) 70.4 (7.3) 68.6 (3.9) 1.6 1.2
 Bipolar 57.9 (14.3) 47.1 (15.6) 55.9 (6.8) 0.3 0.1
 Any 68.7 (5.2) 69.1 (6.9) 65.6 (3.4) 1.3 0.0
III. Behavior disorders
 ADHD 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) – –
 Conduct Disorder – – – – 100.0 (0.0) – –
 ODD 100.0 (0.0) 100.0 (0.0) 100.0 (0.0) – –
 IED 81.2 (14.9) 75.2 (12.6) 88.4 (4.9) 0.9 0.9
 Any 81.4 (14.8) 86.3 (8.3) 94.3 (3.0) 1.4 1.6
IV. Substance disorders
 Alcohol Abuse 24.0 (10.2) 47.5 (17.3) 42.4 (8.6) 4.2* 1.1
 Alcohol Dependence 19.3 (14.1) 31.5 (17.6) 23.0 (9.2) 320.2* 2.2
 Drug Abuse 20.3 (13.3) 46.0 (30.3) 73.1 (9.4) 2.5 2.6
 Drug Dependence 100.0 (0.0) 55.9 (24.1) 61.1 (18.2) – –
 Any 24.9 (8.5) 56.8 (13.0) 48.9 (6.6) 6.3* 3.0
V. Total disorders
 Any 87.1 (2.2) 85.2 (3.9) 89.9 (1.5) 0.2 1.3
*Significant at the .05 level.
1
Pre-matriculation onset disorders were defined as those with onsets at ages 0–17.
2
Post-matriculation onset disorders were defined as those with onsets at ages 18+.
3
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
4
“All other” respondents were defined as those who never entered college whether or not they graduated from secondary 
school
Appendix Table 9
Pooled lifetime prevalence of pre-matriculation onset DSM-IV/CIDI mental disorders1 
separately among male respondents ages 18–22 who entered college (both current students 
and attriters), secondary school graduates in the same age range who never entered college, 
and all other respondents2 in the same age range3
College entrants (CE)
Other respondents who were 
secondary school…
Graduates (GR) Total4 CE: GR5 CE: Total5
% (se) % (se) % (se) OR (95 % CI) AUC OR (95 % CI) AUC
I. Anxiety disorders
 Separation Anxiety Disorder 2.8 (0.4) 3.9 (0.7) 3.4 (0.5) 0.8 (0.3–2.2) 0.85 0.8 (0.3–1.8) 0.85
 Panic Disorder 1.0 (0.2) 1.2 (0.2) 0.9 (0.2) 0.7 (0.3–1.7) 0.69 1.1 (0.4–2.8) 0.66
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College entrants (CE)
Other respondents who were 
secondary school…
Graduates (GR) Total4 CE: GR5 CE: Total5
% (se) % (se) % (se) OR (95 % CI) AUC OR (95 % CI) AUC
 GAD 0.7 (0.2) 1.1 (0.2) 0.9 (0.3) 0.5 (0.2–1.7) 0.74 0.7 (0.2–1.9) 0.74
 Any Phobia 8.9 (0.5) 10.1 (0.9) 9.3 (0.8) 0.8 (0.5–1.3) 0.65 0.9 (0.6–1.3) 0.65
 PTSD 0.9 (0.3) 1.0 (0.6) 0.8 (0.3) 0.8 (0.2–4.3) 0.75 0.9 (0.2–3.2) 0.75
 Any 12.7 (0.8) 13.9 (1.0) 12.3 (0.9) 0.9 (0.6–1.3) 0.66 1.0 (0.7–1.4) 0.66
II. Mood disorders
 MDD 3.9 (0.5) 4.7 (0.5) 4.5 (0.5) 0.6 (0.4–1.0) 0.66 0.6* (0.4–0.9) 0.66
 Bipolar 2.4 (0.5) 3.2 (0.6) 2.8 (0.5) 0.7 (0.3–1.4) 0.75 0.7 (0.4–1.3) 0.75
 Any 6.2 (0.7) 7.7 (0.8) 7.2 (0.7) 0.7 (0.4–1.0) 0.68 0.7* (0.5–1.0) 0.68
III. Behavior disorders
 ADHD 2.7 (0.4) 2.6 (0.2) 2.2 (0.4) 1.0 (0.5–1.9) 0.85 1.0 (0.6–1.7) 0.85
 Conduct Disorder 2.1 (0.5) 3.2 (0.4) 3.7 (0.5) 0.6* (0.3–1.0) 0.88 0.4* (0.2–0.8) 0.87
 ODD 2.7 (0.4) 3.0 (0.5) 3.0 (0.5) 0.9 (0.4–1.7) 0.87 0.8 (0.4–1.3) 0.87
 IED 4.2 (0.7) 2.6 (0.3) 3.1 (0.4) 1.7 (1.0–2.8) 0.83 1.2 (0.8–1.9) 0.82
 Any 8.2 (0.8) 8.8 (0.7) 8.5 (0.8) 0.9 (0.6–1.3) 0.82 0.8 (0.6–1.1) 0.82
IV. Substance disorders
 Alcohol Abuse 3.0 (0.4) 3.7 (0.5) 4.8 (0.6) 0.7 (0.4–1.2) 0.75 0.5* (0.3–0.8) 0.75
 Alcohol Dependence 1.2 (0.4) 1.1 (0.4) 2.0 (0.3) 1.1 (0.4–2.7) 0.81 0.5 (0.3–1.1) 0.80
 Drug Abuse 2.5 (0.4) 2.5 (0.5) 2.8 (0.5) 0.9 (0.5–1.7) 0.79 0.7 (0.4–1.2) 0.78
 Drug Dependence 1.1 (0.3) 0.9 (0.2) 1.5 (0.3) 1.2 (0.4–3.7) 0.83 0.7 (0.3–1.5) 0.81
 Any 6.6 (0.7) 6.1 (0.7) 8.8 (0.7) 1.0 (0.7–1.5) 0.77 0.6* (0.4–0.8) 0.76
V. Total disorders
 Any 23.5 (1.1) 24.3 (1.2) 24.8 (1.2) 0.9 (0.7–1.2) 0.70 0.8 (0.6–1.0) 0.70
 (n) (1,017) (695) (1,550)
*Significant at the .05 level, two-sided test
1
Pre-matriculation onset disorders were defined as those with onsets at ages 0–17.
2
“All other” respondents were defined as those who never entered college whether or not graduated from secondary school.
3
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
4Secondary school graduates or non-graduates.
5
Based on a single pooled logistic model for each row in which separate dummy variables for being an attriter or other 
nonstudent were included as predictors of the mental disorder in the row heading or, in the case of Part VI, number of 
disorders estimated in an ordered logistic framework, controlling age-sex and survey
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Appendix Table 10
Pooled lifetime prevalence of pre-matriculation onset DSM-IV/CIDI mental disorders1 
separately among female respondents ages 18–22 who entered college (both current students 
and attriters), secondary school graduates in the same age range who never entered college, 
and all other respondents2 in the same age range3
College entrants (CE)
Other respondents who were 
secondary school…
Graduates (GR) Total4 CE: GR5 CE: Total5
% (se) % (se) % (se) OR (95 % CI) AUC OR (95 % CI) AUC
I. Anxiety disorders
 Separation Anxiety Disorder 2.0 (0.2) 4.5 (0.6) 4.5 (0.6) 0.4* (0.3–0.8) 0.85 0.4* (0.2–0.6) 0.85
 Panic Disorder 1.2 (0.2) 1.7 (0.3) 1.9 (0.3) 0.5* (0.3–0.9) 0.71 0.5* (0.3–0.8) 0.72
 GAD 1.1 (0.3) 1.3 (0.2) 1.4 (0.3) 0.7 (0.3–1.4) 0.78 0.6 (0.3–1.2) 0.77
 Any Phobia 14.4 (0.9) 17.4 (1.0) 15.7 (1.0) 0.8 (0.6–1.1) 0.66 0.9 (0.7–1.2) 0.66
 PTSD 2.9 (0.4) 4.2 (0.6) 3.9 (0.5) 0.5* (0.3–0.9) 0.80 0.5* (0.3–0.8) 0.80
 Any 18.7 (1.0) 23.7 (1.2) 22.2 (1.2) 0.7* (0.5–0.9) 0.69 0.7* (0.6–0.9) 0.69
II. Mood disorders
 MDD 7.9 (0.6) 7.5 (0.5) 7.1 (0.6) 1.0 (0.7–1.4) 0.69 1.0 (0.7–1.4) 0.69
 Bipolar 1.8 (0.4) 1.5 (0.3) 2.0 (0.3) 1.2 (0.6–2.1) 0.76 0.9 (0.5–1.5) 0.75
 Any 9.7 (0.7) 9.0 (0.6) 9.0 (0.7) 1.0 (0.8–1.4) 0.71 1.0 (0.7–1.2) 0.70
III. Behavior disorders
 ADHD 1.5 (0.2) 1.5 (0.4) 1.9 (0.4) 1.3 (0.5–3.4) 0.85 0.7 (0.4–1.3) 0.83
 Conduct Disorder 1.1 (0.1) 2.6 (0.3) 2.0 (0.4) 0.4* (0.2–0.9) 0.90 0.4* (0.2–0.7) 0.90
 ODD 2.0 (0.3) 3.1 (0.5) 2.8 (0.5) 0.7 (0.3–1.5) 0.86 0.5 (0.3–1.0) 0.85
 IED 2.0 (0.3) 2.6 (0.4) 2.3 (0.3) 0.9 (0.6–1.5) 0.84 0.8 (0.5–1.3) 0.84
 Any 5.3 (0.4) 6.9 (0.6) 6.6 (0.7) 0.8 (0.5–1.3) 0.83 0.6* (0.5–0.9) 0.82
IV. Substance disorders
 Alcohol Abuse 1.9 (0.4) 3.4 (0.4) 3.1 (0.4) 0.4* (0.2–0.8) 0.82 0.4* (0.2–0.7) 0.81
 Alcohol Dependence 0.5 (0.1) 0.6 (0.1) 0.6 (0.1) 0.9 (0.3–2.3) 0.89 0.8 (0.4–1.7) 0.89
 Drug Abuse 0.9 (0.3) 1.5 (0.2) 1.8 (0.3) 0.5 (0.2–1.1) 0.87 0.4* (0.2–0.8) 0.87
 Drug Dependence 0.8 (0.2) 1.1 (0.3) 0.9 (0.2) 0.6 (0.3–1.6) 0.81 0.7 (0.3–1.4) 0.81
 Any 3.3 (0.5) 5.3 (0.5) 5.2 (0.5) 0.5* (0.3–0.8) 0.83 0.4* (0.3–0.7) 0.83
V. Total disorders
 Any 27.1 (1.2) 31.8 (1.3) 29.4 (1.3) 0.7* (0.6–0.9) 0.71 0.8* (0.6–1.0) 0.71
  (n) (1,257) (876) (1,926)
*Significant at the .05 level, two-sided test
1
Pre-matriculation onset disorders were defined as those with onsets at ages 0–17.
2
“All other” respondents were defined as those who never entered college whether or not graduated from secondary school.
3
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
4Secondary school graduates or non-graduates.
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5
Based on a single pooled logistic model for each row in which separate dummy variables for being an attriter or other 
nonstudent were included as predictors of the mental disorder in the row heading or, in the case of Part VI, number of 
disorders estimated in an ordered logistic framework, controlling age-sex and survey.
Appendix Table 11
Pooled lifetime prevalence of pre-matriculation1 and post-matriculation2 onset DSM-IV/
CIDI mental disorders separately among male respondents ages 18–22 who were current 
students or college attriters3
Students (ST) Attriters (AT) Students vs. Attriters
Pre- Post- Pre- Post- Pre-4 Post-4
% (se) % (se) % (se) % (se) OR (95 % CI) AUC OR (95 % CI) AUC
I. Anxiety disorders
 Separation Anxiety Disorder 3.7 (1.5) 1.0 (0.3) 0.8 (0.5) 0.6 (0.3) 3.7 (0.9–15.9) 0.91 2.7 (0.7–10.2) 0.88
 Panic Disorder 1.0 (0.5) 1.1 (0.5) 1.0 (0.6) 0.0 (0.0) 1.1 (0.3–4.7) 0.67 115.4* (9.3–999.9+) 0.87
 GAD 0.5 (0.3) 0.3 (0.1) 1.2 (0.7) 0.3 (0.2) 0.5 (0.1–2.4) 0.74 1.9 (0.3–11.7) 0.85
 Any Phobia 8.9 (1.2) 0.4 (0.3) 8.8 (2.7) 2.0 (0.9) 1.2 (0.6–2.3) 0.66 0.2 (0.0–1.6) 0.80
 PTSD 0.6 (0.3) 0.3 (0.2) 1.5 (0.9) 0.0 (0.0) 0.7 (0.2–3.5) 0.76 – – –
 Any 13.2 (1.9) 1.7 (0.4) 11.4 (2.8) 3.0 (1.0) 1.3 (0.7–2.5) 0.66 1.0 (0.4–2.6) 0.80
II. Mood disorders
 MDD 3.2 (0.6) 3.0 (0.7) 5.6 (1.3) 4.4 (1.2) 0.9 (0.4–1.8) 0.66 1.1 (0.4–2.9) 0.70
 Bipolar 1.8 (0.5) 0.5 (0.2) 3.6 (1.1) 1.1 (0.4) 0.5 (0.2–1.3) 0.75 0.7 (0.2–3.3) 0.80
 Any 5.0 (0.8) 3.5 (0.7) 9.2 (1.8) 5.7 (1.4) 0.7 (0.4–1.3) 0.68 1.0 (0.4–2.4) 0.72
III. Behavior disorders
 ADHD 2.2 (0.7) 0.0 (0.0) 3.7 (1.4) 0.0 (0.0) 0.9 (0.3–2.6) 0.85 –5 – –
 Conduct Disorder 1.7 (0.6) 0.0 (0.0) 3.0 (1.2) 0.0 (0.0) 0.7 (0.2–2.1) 0.87 –5 – –
 ODD 2.2 (0.6) 0.0 (0.0) 3.7 (1.1) 0.0 (0.0) 0.7 (0.3–1.6) 0.87 –5 – –
 IED 4.1 (0.9) 0.2 (0.1) 4.6 (1.1) 0.2 (0.1) 1.0 (0.5–1.9) 0.82 1.2 (0.2–6.9) 0.87
 Any 7.6 (1.2) 0.2 (0.1) 9.7 (1.9) 0.2 (0.1) 1.0 (0.5–1.8) 0.82 1.1 (0.2–7.0) 0.88
IV. Substance disorders
 Alcohol Abuse 2.0 (0.4) 3.5 (0.7) 5.2 (1.3) 8.4 (1.9) 0.4* (0.2–0.8) 0.75 0.7 (0.4–1.5) 0.76
 Alcohol Dependence 0.8 (0.4) 1.1 (0.4) 2.0 (0.7) 1.3 (0.5) 0.4 (0.1–1.5) 0.81 1.4 (0.5–4.0) 0.78
 Drug Abuse 1.3 (0.5) 0.4 (0.2) 5.3 (1.2) 0.7 (0.4) 0.2* (0.1–0.7) 0.81 0.9 (0.2–4.0) 0.76
 Drug Dependence 0.6 (0.3) 0.0 (0.0) 2.4 (1.0) 0.5 (0.3) 0.2 (0.1–1.0) 0.82 0.2 (0.0–2.1) 0.84
 Any 4.5 (0.8) 4.0 (0.8) 11.3 (1.8) 10.3 (2.1) 0.4* (0.2–0.7) 0.77 0.6 (0.3–1.3) 0.77
V. Total disorders
 Any 20.9 (2.2) 7.0 (0.9) 29.5 (3.3) 13.2 (2.3) 0.8 (0.5–1.2) 0.70 0.9 (0.5–1.6) 0.70
  (n) (747) –6 (270) –7
*Significant at the .05 level, two-sided test
1
Pre-matriculation onset disorders were defined as those with onsets at ages 0–17.
2
Post-matriculation onset disorders were defined as those with onsets at ages 18+.
3
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
4
Based on a pooled within-survey logistic regression equation adjusting for between-survey variation in the association of 
age-sex with student status
5
There were no post-matriculation onsets of these disorders by definition, as the CIDI required onsets before age 8 
(ADHD) or 18 (Conduct Disorder, Oppositional Defiant Disorder).
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6
Prevalence of post-matriculation onsets was estimated in the subsample of respondents who did not have a pre-
matriculation history of the disorder. As a result, the sample size for each calculation varies across disorders from a low of 
653 among male students who had no pre-matriculation history of specific phobias to a high of 742 among male students 
who had no pre-matriculation history of drug dependence, with a median sample size of 731. The sample size for having no 
pre-matriculation history of any disorder is 544 among male students.
7
Prevalence of post-matriculation onsets was estimated in the subsample of respondents who did not have a pre-
matriculation history of the disorder. As a result, the sample size for each calculation varies across disorders from a low of 
239 among male attriters who had no pre-matriculation history of specific phobias to a high of 267 among male attriters 
who had no pre-matriculation history of panic disorder, with a median sample size of 256. The sample size for having no 
pre-matriculation history of any disorder is 170 among male attriters.
Appendix Table 12
Pooled lifetime prevalence of pre-matriculation1 and post-matriculation2 onset DSM-IV/
CIDI mental disorders separately among female respondents ages 18–22 who were current 
students or college attriters3
Students (ST) Attriters (AT) Students vs. Attriters
Pre- Post- Pre- Post- Pre-4 Post-4
% (se) % (se) % (se) % (se) OR (95 % CI) AUC OR (95 % CI) AUC
I. Anxiety disorders
 Separation Anxiety Disorder 1.7 (0.5) 0.5 (0.2) 2.8 (0.9) 1.6 (0.5) 0.7 (0.3–1.7) 0.85 0.5 (0.2–1.3) 0.89
 Panic Disorder 1.2 (0.2) 0.2 (0.1) 1.3 (0.4) 0.6 (0.3) 1.8 (0.9–3.8) 0.72 0.9 (0.2–3.5) 0.93
 GAD 1.0 (0.3) 0.2 (0.0) 1.4 (0.7) 1.4 (0.5) 1.0 (0.3–3.0) 0.77 0.2* (0.1–0.5) 0.80
 Any Phobia 13.8 (2.0) 0.6 (0.1) 15.5 (1.6) 0.6 (0.2) 0.9 (0.6–1.3) 0.66 3.0 (0.9–10.5) 0.71
 PTSD 1.6 (0.5) 1.0 (0.2) 5.5 (1.1) 1.4 (0.5) 0.5 (0.2–1.0) 0.82 1.9 (0.8–4.7) 0.79
 Any 17.1 (2.0) 1.3 (0.3) 22.0 (2.0) 2.7 (0.7) 0.9 (0.6–1.2) 0.69 1.1 (0.5–2.4) 0.76
II. Mood disorders
 MDD 6.5 (0.9) 3.8 (0.8) 10.8 (1.5) 3.6 (0.9) 0.6* (0.4–1.0) 0.69 1.7 (0.9–3.3) 0.73
 Bipolar 1.9 (0.6) 1.1 (0.5) 1.6 (0.4) 1.4 (0.7) 1.3 (0.6–2.8) 0.75 1.6 (0.4–6.0) 0.78
 Any 8.3 (0.9) 4.4 (0.9) 12.3 (1.6) 4.7 (1.1) 0.7 (0.4–1.1) 0.71 1.6 (0.9–2.9) 0.73
III. Behavior disorders
 ADHD 1.5 (0.6) 0.0 (0.0) 1.6 (0.4) 0.0 (0.0) 1.4 (0.6–3.3) 0.83 –5 – –
 Conduct Disorder 0.7 (0.3) 0.0 (0.0) 1.9 (0.6) 0.0 (0.0) 0.6 (0.2–1.6) 0.89 –5 – –
 ODD 1.5 (0.6) 0.0 (0.0) 2.8 (0.8) 0.0 (0.0) 0.6 (0.2–1.9) 0.85 –5 – –
 IED 1.6 (0.3) 0.3 (0.3) 2.9 (0.9) 0.8 (0.5) 0.6 (0.3–1.1) 0.84 0.8 (0.1–5.8) 0.90
 Any 4.0 (0.7) 0.3 (0.3) 7.8 (1.3) 0.7 (0.5) 0.6 (0.3–1.0) 0.83 0.9 (0.1–7.7) 0.92
IV. Substance disorders
 Alcohol Abuse 1.0 (0.3) 1.7 (0.3) 3.8 (1.2) 3.1 (1.2) 0.4* (0.1–0.9) 0.81 1.1 (0.4–2.9) 0.80
 Alcohol Dependence 0.4 (0.2) 1.2 (0.5) 0.8 (0.3) 2.1 (1.0) 0.3 (0.1–1.3) 0.89 1.4 (0.4–4.9) 0.81
 Drug Abuse 0.5 (0.2) 0.5 (0.1) 1.6 (0.8) 1.7 (0.9) 0.4 (0.1–1.7) 0.87 0.8 (0.3–2.4) 0.86
 Drug Dependence 0.2 (0.2) 0.2 (0.1) 1.9 (0.6) 0.7 (0.4) 0.2* (0.0–0.8) 0.84 0.7 (0.1–5.2) 0.89
 Any 1.7 (0.4) 3.1 (0.6) 6.4 (1.5) 5.5 (1.5) 0.4* (0.2–0.7) 0.84 1.3 (0.7–2.6) 0.82
V. Total disorders
 Any 25.1 (2.4) 6.4 (1.1) 31.0 (2.5) 8.9 (1.8) 0.9 (0.6–1.2) 0.71 1.8 (1.0–3.3) 0.75
 (n) (825) –6 (432) –7
*Significant at the .05 level, two-sided test
1
Pre-matriculation onset disorders were defined as those with onsets at ages 0–17.
2
Post-matriculation onset disorders were defined as those with onsets at ages 18+.
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3
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
4
Based on a pooled within-survey logistic regression equation adjusting for between-survey variation in the association of 
age-sex with student status
5
There were no post-matriculation onsets of these disorders by definition, as the CIDI required onsets before age 8 
(ADHD) or 18 (Conduct Disorder, Oppositional Defiant Disorder).
6
Prevalence of post-matriculation onsets was estimated in the subsample of respondents who did not have a pre-
matriculation history of the disorder. As a result, the sample size for each calculation varies across disorders from a low of 
683 among female students who had no pre-matriculation history of specific phobias to a high of 821 among female 
students who had no pre-matriculation history of drug dependence, with a median sample size of 810. The sample size for 
having no pre-matriculation history of any disorder is 558 among female students.
7
Prevalence of post-matriculation onsets was estimated in the subsample of respondents who did not have a pre-
matriculation history of the disorder. As a result, the sample size for each calculation varies across disorders from a low of 
335 among female attriters who had no pre-matriculation history of specific phobias to a high of 425 among female attriters 
who had no pre-matriculation history of drug abuse, with a median sample size of 418. The sample size for having no pre-
matriculation history of any disorder is 259 among female attriters.
Appendix Table 13
Pooled proportions of male respondents with 12-month DSM-IV/CIDI mental disorders who 
received minimally adequate treatment for these disorders in the 12 months before interview 
by country income level separately among respondents who were current students, college 
attriters, and nonstudents in the same age range1
Students Attriters Others
% (se) (n) % (se) (n) % (se) (n)
Low/lower-middle 11.1 (6.5) (4) 0.0 – (0) 5.7 (3.2) (4)
Upper-middle 9.1 (8.6) (1) 14.5 (10.6) (3) 7.5 (3.5) (5)
High 26.7 (7.6) (15) 13.5 (5.8) (8) 14.9 (3.6) (17)
Total 18.3 (4.5) (20) 13.0 (4.8) (11) 9.9 (2.0) (26)
χ22 6.836* 0.0 2.0
*Significant at the .05 level, two-sided test
1
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
Appendix Table 14
Pooled proportions of female respondents with 12-month DSM-IV/CIDI mental disorders 
who received minimally adequate treatment for these disorders in the 12 months before 
interview by country income level separately among respondents who were current students, 
college attriters, and nonstudents in the same age range1
Students Attriters Others
% (se) (n) % (se) (n) % (se) (n)
Low/lower-middle 0.7 (0.7) (1) 2.7 (2.7) (1) 6.5 (4.3) (4)
Upper-middle 13.2 (6.3) (5) 4.7 (3.5) (2) 9.1 (2.8) (13)
High 20.3 (3.4) (18) 31.6 (5.4) (26) 16.7 (3.3) (30)
Total 14.7 (2.5) (24) 20.1 (4.1) (29) 11.0 (2.0) (47)
χ22 13.741* 11.683* 5.8
*Significant at the .05 level, two-sided test
1
Respondents were limited to those in the Part II sample who were 18–22 years old at the time of interview and had not 
graduated from college.
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